
pmid: 19646644
Hepatic encephalopathy is characterized by a wide spectrum of neuropsychiatric abnormalities and motor disturbances in patients with advanced liver disease. It is estimated to occur in 30% to 45% of patients with liver cirrhosis and in 10% to 50% of patients with transjugular intrahepatic portosystemic shunts. It can be seen in cancer patients due to multiple factors. Early diagnosis and treatment are important but can be challenging, especially in mild forms with subtle findings. This article reviews the pathogenesis, diagnostic criteria, grading, and management of hepatic encephalopathy.
Antineoplastic Agents, Brain Edema, Liver Failure, Acute, Prognosis, Severity of Illness Index, Hepatic Encephalopathy, Neoplasms, Humans, Neoplasm Invasiveness, Intracranial Hypertension
Antineoplastic Agents, Brain Edema, Liver Failure, Acute, Prognosis, Severity of Illness Index, Hepatic Encephalopathy, Neoplasms, Humans, Neoplasm Invasiveness, Intracranial Hypertension
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 41 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
